相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dapagliflozin attenuates cholesterol overloading-induced injury in mice hepatocytes with type 2 diabetes mellitus (T2DM) via eliminating oxidative damages
Liu Yang et al.
CELL CYCLE (2022)
Dapagliflozin Improves Cardiac Function, Remodeling, Myocardial Apoptosis, and Inflammatory Cytokines in Mice with Myocardial Infarction
Kai Wang et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2022)
Dapagliflozin protects against doxorubicin-induced cardiotoxicity by restoring STAT3
Wei-Ting Chang et al.
ARCHIVES OF TOXICOLOGY (2022)
The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury
Eslam E. Abd El-Fattah et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation
Reem M. Hazem et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients
Wei-Ting Chang et al.
ARCHIVES OF TOXICOLOGY (2021)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial
Jawad H. Butt et al.
CIRCULATION-HEART FAILURE (2021)
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
Kun-Ling Tsai et al.
CELL AND BIOSCIENCE (2021)
Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats
Nora El-Sayed et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2021)
Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation
Mi Na Kim et al.
DIABETES OBESITY & METABOLISM (2021)
Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats
Jingjing Tian et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/ streptozotocin-induced diabetes mellitus
Konstantin N. Belosludtsev et al.
MITOCHONDRION (2021)
Reactive fibrosis precedes doxorubicin-induced heart failure through sterile inflammation
Ryo Tanaka et al.
ESC HEART FAILURE (2020)
Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation
Hsin-Lun Yang et al.
CANCERS (2020)
Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts
Scott P. Levick et al.
HEART LUNG AND CIRCULATION (2019)
Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration
Chowdhury S. Abdullah et al.
SCIENTIFIC REPORTS (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Mitochondrial dysfunction and oxidative stress in heart disease
Jessica N. Peoples et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Progressive 3-Month Increase in LV Myocardial ECV After Anthracycline-Based Chemotherapy
Giselle C. Melendez et al.
JACC-CARDIOVASCULAR IMAGING (2017)
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao et al.
SCIENTIFIC REPORTS (2017)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Chemotherapy-Induced Cardiotoxicity: Overview of the Roles of Oxidative Stress
Paweorn Angsutararux et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
Risto Kerkela et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA
Stale H. Nymo et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Manipulation of Cardiac Phosphatidylinositol 3-Kinase (PI3K)/Akt Signaling by Apoptosis Regulator through Modulating IAP Expression (ARIA) Regulates Cardiomyocyte Death during Doxorubicin-induced Cardiomyopathy
Youhei Kitamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
Siying Li et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
Run-Min Guo et al.
MOLECULAR MEDICINE REPORTS (2013)
Embryonic Stem Cells Improve Cardiac Function in Doxorubicin-Induced Cardiomyopathy Mediated Through Multiple Mechanisms
Dinender K. Singla et al.
CELL TRANSPLANTATION (2012)
Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress
Jinqing Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
Vilma A. Sardao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection
Henryk Dreger et al.
CARDIOVASCULAR RESEARCH (2009)
Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets
Vilma A. Sardao et al.
CELL BIOLOGY AND TOXICOLOGY (2009)
Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β
Rudolf Jarai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE
Ling Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction
T Nousiainen et al.
JOURNAL OF INTERNAL MEDICINE (2002)
CXC-chemokines, a new group of cytokines in congestive heart failure -: possible role of platelets and monocytes
JK Damås et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
